DIAGNOS Announces Grant of Stock Options and Adoption of Semi-Annual Reporting (opens original article in a new tab)

DIAGNOS announces granting 1.5 million stock options to directors and officers with a C$0.20 exercise price and adopts semi-annual reporting for more efficient financial reporting.

• DIAGNOS grants 1,500,000 stock options to directors and officers with an exercise price of C$0.20 per share.
• The company adopts semi-annual reporting under the Canadian Securities Administrators' pilot program to improve financial reporting efficiency.
• Stock options vest over two years and expire on June 11, 2031.